Note: Responses were lightly edited for style.
Charles Elmaraghy, MD. Chief of Pediatric Otolaryngology at Nationwide Children’s Hospital (Columbus, Ohio): Most pressing regulatory issues for ENT continue to be support for pediatric healthcare. The Children’s Health Insurance Program has received bipartisan support, but the funding is critical to keeping pediatric healthcare as a priority.
Nicole Aaronson, MD. Pediatric Otolaryngologist at Alfred I. duPont Hospital (Wilmington, Del.): The Center for Medicare & Medicaid Services and The Joint Commission are two important regulatory agencies that affect ENT. Reimbursement rates, billing and coding regulations, and rules regarding scope of practice and conflict of interest are set by CMS.
ENT practices need to make sure to stay in compliance with these regulatory changes as they occur. The Joint Commission, which is a body responsible for hospital accreditation, also has frequently changing rules for inpatient and outpatient processes. Some of the regulations that most affect ENT impact how clinic instrumentation, including flexible fiberoptic laryngoscopes, have to be processed and handled. More stringent requirements for instrument processing, handling and storage have significant ramifications on clinical workflow and productivity.
More articles on surgery centers:
15 ASCs opened or announced in March
CEO predicts Biden’s $1.9 trillion plan will help ASCs
ASCs return to growth: Big plans from innovative execs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
